23948sdkhjf

Fakta om udbudet

EU-nr
2019/S 052-119721
Offentliggjort
14.03.2019
Udbudstype
Offentligt udbud

Udbyder

Karolinska Universitetssjukhuset

Vindere

(31.07.2019)
CSM Europe sa
rue Granbonpré 11
B-1435 Mont-Saint-Guibert

Handling and Distribution of Investigational Medicinal Product (IMP)


Karolinska Universitetssjukhuset

Contract notice

Services

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1) Name and addresses
Karolinska Universitetssjukhuset
232100-0016
Inköpsavdelningen NS3
Stockholm
171 76
Sweden
Contact person: Pia Lindström
E-mail: pia.lindstrom@sll.se
NUTS code: SE11

Internet address(es):

Main address: http://www.karolinska.se

I.2) Information about joint procurement
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at: https://tendsign.com/doc.aspx?UniqueId=afesbalbmx&GoTo=Docs
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: https://tendsign.com/doc.aspx?UniqueId=afesbalbmx&GoTo=Tender
I.4) Type of the contracting authority
Regional or local authority
I.5) Main activity
Health

Section II: Object

II.1) Scope of the procurement
II.1.1) Title:

Handling and Distribution of Investigational Medicinal Product (IMP)

Reference number: 18-541
II.1.2) Main CPV code
63100000
II.1.3) Type of contract
Services
II.1.4) Short description:

Karolinska University Hospital performs this procurement of handling and distribution of an Investigational Medicinal Product (IMP), as part of a clinical sub study where 14 European countries are participating and where Karolinska is sponsor.

II.1.5) Estimated total value
II.1.6) Information about lots
This contract is divided into lots: no
II.2) Description
II.2.1) Title:
II.2.2) Additional CPV code(s)
II.2.3) Place of performance
NUTS code: SE11
II.2.4) Description of the procurement:

Karolinska University Hospital performs this procurement of handling and distribution of an Investigational Medicinal Product (IMP), as part of a clinical sub study where 14 European countries are participating and where Karolinska is sponsor.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
End: 31/12/2026
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information

Section III: Legal, economic, financial and technical information

III.1) Conditions for participation
III.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
III.1.2) Economic and financial standing
III.1.3) Technical and professional ability
III.1.5) Information about reserved contracts
III.2) Conditions related to the contract
III.2.1) Information about a particular profession
III.2.2) Contract performance conditions:
III.2.3) Information about staff responsible for the performance of the contract

Section IV: Procedure

IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.3) Information about a framework agreement or a dynamic purchasing system
IV.1.4) Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6) Information about electronic auction
IV.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
IV.2.2) Time limit for receipt of tenders or requests to participate
Date: 18/04/2019
Local time: 23:59
IV.2.3) Estimated date of dispatch of invitations to tender or to participate to selected candidates
IV.2.4) Languages in which tenders or requests to participate may be submitted:
English
IV.2.6) Minimum time frame during which the tenderer must maintain the tender
Tender must be valid until: 18/07/2019
IV.2.7) Conditions for opening of tenders
Date: 19/04/2019
Local time: 00:00

Section VI: Complementary information

VI.1) Information about recurrence
This is a recurrent procurement: no
VI.2) Information about electronic workflows
VI.3) Additional information:
VI.4) Procedures for review
VI.4.1) Review body
Förvaltningsrätten i Stockholm
Stockholm
Sweden
VI.4.2) Body responsible for mediation procedures
VI.4.3) Review procedure
VI.4.4) Service from which information about the review procedure may be obtained
VI.5) Date of dispatch of this notice:
11/03/2019

Send til en kollega

0.11